Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matveev

Showing results (961-970 of 1,381) with videos related to

Pageof 139
Sort By:
Molecular Informatics|September 8, 2022
Computer-aided Evaluation of Polyvalent Medications' Pharmacological Potential. Multiphytoadaptogen as a Case StudyO A Bocharova, N S Ionov, I V Kazeev, et al.
Plos One|July 16, 2009
An analysis of growth, differentiation and apoptosis genes with risk of renal cancerLinda M Dong, Paul Brennan, Sara Karami, et al.
Plos Genetics|October 25, 2011
Von Hippel-Lindau (VHL) inactivation in sporadic clear cell renal cancer: associations with germline VHL polymorphisms and etiologic risk factorsLee E Moore, Michael L Nickerson, Paul Brennan, et al.
The Lancet. Oncology|November 12, 2013
Docetaxel and dasatinib or placebo in men with metastatic castration-resistant prostate cancer (READY): a randomised, double-blind phase 3 trialJohn C Araujo, Géralyn C Trudel, Fred Saad, et al.
European Urology|December 23, 2015
Role of Hormonal Treatment in Prostate Cancer Patients with Nonmetastatic Disease Recurrence After Local Curative Treatment: A Systematic ReviewRoderick C N van den Bergh, Niels J van Casteren, Thomas van den Broeck, et al.
International Journal of Cancer|November 15, 2012
An investigation of risk factors for renal cell carcinoma by histologic subtype in two case-control studiesMark P Purdue, Lee E Moore, Maria J Merino, et al.
European Urology|August 30, 2016
EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative IntentNicolas Mottet, Joaquim Bellmunt, Michel Bolla, et al.
European Urology Focus|August 15, 2024
Testicular Germ Cell Tumors with Venous Tumor Thrombus: Prevalence, Presentation, and ManagementSophia Y Chahine, Khalid Y Alkhatib, Gevorg Arakelyan, et al.
European Urology|January 28, 2017
The Benefits and Harms of Different Extents of Lymph Node Dissection During Radical Prostatectomy for Prostate Cancer: A Systematic ReviewNicola Fossati, Peter-Paul M Willemse, Thomas Van den Broeck, et al.
European Urology Oncology|September 11, 2024
Liquid Biopsy in Progressing Prostate Cancer Patients Starting Docetaxel with or Without Enzalutamide: A Biomarker Study of the PRESIDE Phase 3b TrialMaria Ruiz-Vico, Daniel Wetterskog, Francesco Orlando, et al.
Pageof 139

Showing results (961-970 of 1,381) with videos related to

Sort By:
Pageof 139
Molecular Informatics|September 8, 2022
Computer-aided Evaluation of Polyvalent Medications' Pharmacological Potential. Multiphytoadaptogen as a Case StudyO A Bocharova, N S Ionov, I V Kazeev, et al.
Plos One|July 16, 2009
An analysis of growth, differentiation and apoptosis genes with risk of renal cancerLinda M Dong, Paul Brennan, Sara Karami, et al.
Plos Genetics|October 25, 2011
Von Hippel-Lindau (VHL) inactivation in sporadic clear cell renal cancer: associations with germline VHL polymorphisms and etiologic risk factorsLee E Moore, Michael L Nickerson, Paul Brennan, et al.
The Lancet. Oncology|November 12, 2013
Docetaxel and dasatinib or placebo in men with metastatic castration-resistant prostate cancer (READY): a randomised, double-blind phase 3 trialJohn C Araujo, Géralyn C Trudel, Fred Saad, et al.
European Urology|December 23, 2015
Role of Hormonal Treatment in Prostate Cancer Patients with Nonmetastatic Disease Recurrence After Local Curative Treatment: A Systematic ReviewRoderick C N van den Bergh, Niels J van Casteren, Thomas van den Broeck, et al.
International Journal of Cancer|November 15, 2012
An investigation of risk factors for renal cell carcinoma by histologic subtype in two case-control studiesMark P Purdue, Lee E Moore, Maria J Merino, et al.
European Urology|August 30, 2016
EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative IntentNicolas Mottet, Joaquim Bellmunt, Michel Bolla, et al.
European Urology Focus|August 15, 2024
Testicular Germ Cell Tumors with Venous Tumor Thrombus: Prevalence, Presentation, and ManagementSophia Y Chahine, Khalid Y Alkhatib, Gevorg Arakelyan, et al.
European Urology|January 28, 2017
The Benefits and Harms of Different Extents of Lymph Node Dissection During Radical Prostatectomy for Prostate Cancer: A Systematic ReviewNicola Fossati, Peter-Paul M Willemse, Thomas Van den Broeck, et al.
European Urology Oncology|September 11, 2024
Liquid Biopsy in Progressing Prostate Cancer Patients Starting Docetaxel with or Without Enzalutamide: A Biomarker Study of the PRESIDE Phase 3b TrialMaria Ruiz-Vico, Daniel Wetterskog, Francesco Orlando, et al.
Pageof 139